CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 4 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,738,780 | -31.3% | 234,284 | -21.0% | 0.32% | -27.9% |
| Q2 2023 | $3,984,906 | -21.0% | 296,496 | -2.5% | 0.44% | -27.8% |
| Q1 2023 | $5,043,487 | -10.9% | 304,191 | -0.0% | 0.62% | -14.1% |
| Q4 2022 | $5,658,771 | +44.9% | 304,235 | -0.0% | 0.72% | +6.9% |
| Q3 2022 | $3,904,000 | +82.9% | 304,293 | -0.1% | 0.67% | +28.8% |
| Q2 2022 | $2,135,000 | -15.4% | 304,515 | 0.0% | 0.52% | +1.8% |
| Q1 2022 | $2,524,000 | -38.8% | 304,515 | -50.0% | 0.51% | +21.3% |
| Q4 2021 | $4,124,000 | +155.5% | 609,030 | +100.0% | 0.42% | +19.9% |
| Q3 2021 | $1,614,000 | -54.1% | 304,515 | -50.2% | 0.35% | -44.2% |
| Q2 2021 | $3,514,000 | +24.9% | 611,107 | +0.1% | 0.63% | +23.0% |
| Q1 2021 | $2,814,000 | +123.9% | 610,491 | +62.3% | 0.51% | +91.4% |
| Q4 2020 | $1,257,000 | – | 376,207 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |